Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis

Digestive Diseases and Sciences

Volumn 46, Issue 6, 2001, Pages 1313-1320

  Fernández Rodriguez, Conrado M ^a   Prada, Ignacio ^b   Andrade, Amalia ^b   Moreiras, Mercedes ^b   Guitián, Ramón ^c   Aller, Rocío ^a   Lledó, José L ^a   Cacho, Guillermo ^a   Quiroga, Jorge ^d   Prieto, Jesús ^d  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c MEDTEC   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cirrhosis; Insulinlike growth factor binding proteins; Insulinlike growth factor 1; Renal function

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HUMAN; INSULINEMIA; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY TUBULE; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; SODIUM RETENTION; SODIUM URINE LEVEL; VASODILATATION;

FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RENAL CIRCULATION; RENIN; SODIUM;

EID: 0035015568     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010631800505     Document Type: Article

References (55)

1. Urinary growth hormone excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosis
2. Circulating growth hormone and IGF-1 in non-alcoholic liver cirrhosis with or without superimposed hepatocarcinoma: Evidence of an altered circadian rhythm
3. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: Experience with a new competitive enzyme immunoassay
4. Growth hormone, insulinlike growth factor-1, and insulin like growth factor binding proteins 1 and 3 in chronic liver diseases
5. Insulin-like growth factor-1 serum concentration and pattern of insulinlike growth factor-1 binding proteins in patients with liver diseases
6. Prognostic value of insulinlike growth factor-1 and its binding proteins in patients with alcohol-induced liver disease
7. Prognostic value of generation of growth hormone-estimulated insulin-like growth factor-1 (IGF-I) and its binding protein-3 in patients with compensated and decompensated cirrhosis
8. Insulin-like growth factor I in essential hypertension
9. Effects of insulin-like growth factor I on renal function in normal men
10. Insulin-like growth factor in cirrhosis
11. Effects of the infusion of insulinlike growth factor-1 in a child with growth hormone insensitivity syndrome (Laron dwarfism)
12. Effects of IGF-I on renal function in end-stage chronic renal failure
13. Effect of IGF-I on renal function in patients with chronic renal failure
14. Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor-I during euglycemic clamping in anesthesized rats
15. Effects of growth hormone and insulin-like growth factor I on renal function
16. Insulin-like growth factor increases glomerular filtration rate and renal plasma flow in man
17. Direct demonstration of insulin-like growth factor I-induced nitric oxide production by endothelial cells
18. Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature
19. Transection of the oesophagus for bleeding oesophageal varices
20. The effects of sampling site on the two-dimensional echo-Doppler determination of cardiac output
21. Reproducibility of linear cardiac output measurement by Doppler ultrasound alone
22. Validation of non-invasive measurement of cardiac output. The Ann Arbor experience
23. 99mTc-DTPA: A rapid technique for determining differential glomerular filtration
24. Validation of a simple isotopic technique for the measurement of global and separated renal function
25. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: Relationships with growth hormone and IGFs and physiological significance
26. Growth hormone/insulin-like growth factor 1 axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy
27. Regulation of of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I
28. Failure of insulin-like growth factor-1 (IGF-1) infusion to promote growth in protein restricted rats despite normalization of serum IGF-1 concentrations
29. Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile sub-unit in Laron syndrome patients with normal growth hormone binding protein
30. Concentrations, release, and disposal of insulinlike growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis
31. Effect of partial hepatectomy on hepatic insulinlike growth factor binding protein-1 expression
32. The gene encoding rat insulin-like growth factor binding protein 1 is rapidly and highly induced in regenerating liver
33. Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF binding proteins
34. Insulin regulates the serum levels of low molecular weight growth factor-binding protein
35. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding by insulin
36. High insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance
37. Hyperglucagonemia in cirrhosis: Altered secretion and sensitivity to glucagon
38. Insulin-like growth factor binding protein-1: Recent findings and new directions
39. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart
40. The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro
41. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I
42. Insulin-like growth factors and their binding proteins: Biological actions
43. Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice
44. Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-1 and IG-FBP-1
45. Differential mRNA expression of insulin-like growth factor system during renal injury and hypertrophy
46. Expression of the insulin-like growth factor system in the hypokalemic rat kidney
47. The growth hormone insulin-like growth factor axis in kidney revisited
48. Anatomical relationship in the patterns of insulin-like growth factor (IGF-I), IGF-I binding protein and IGF-I receptor gene expression in the rat kidney
49. Insulin-like growth factor and the kidney: Physiology, pathophysiology, and therapeutics implications
50. Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: Possible involvement of renin and atrial natriuretic factor
51. Growth hormone, the insulin-like growth factor system, and the kidney
52. Acute effect of human recombinant insulin-like growth factor I on renal function in humans
53. + transport in toad urinary bladders
54. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients
55. Pathogenesis of ascites in cirrhosis